Cochrane · systematic review · CD005200

Laparoscopic versus open total mesorectal excision for rectal cancer

Vennix, S, Pelzers, L, Bouvy, N, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

ColorectalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 6 · 85.7%High 1 · 14.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Laparoscopic versus open total mesorectal excision for rectal cancer

Population: people with Rectal Cancer
7 questions
OutcomeEffectEvidenceStatus / GRADE
Disease‐free survival at 5 years
Laparoscopic vs open total mesorectal excision
OR 1.02 [0.76, 1.38]4 studies · 943 participantsModerate
Overall survival at 5 years
Laparoscopic vs open total mesorectal excision
OR 1.15 [0.87, 1.52]4 studies · 987 participantsModerate
Local recurrences
Laparoscopic vs open total mesorectal excision
OR 0.89 [0.57, 1.39]8 studies · 1538 participantsModerate
Lymph nodes retrieved
Laparoscopic vs open total mesorectal excision
no estimate extracted11 studies · 3682 participantsHigh
CRM positivity
Laparoscopic vs open total mesorectal excision
OR 0.99 [0.71, 1.4]8 studies · 2313 participantsModerate
30‐day morbidity (total)
Laparoscopic vs open total mesorectal excision
OR 0.94 [0.8, 1.1]11 studies · 3397 participantsModerate
Hospital stay (days)
Laparoscopic vs open total mesorectal excision
no estimate extracted11 studies · 3084 participantsModerate